The Superdisintegrants Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Superdisintegrants Market is estimated to be USD 332.47 million in 2018 and predicted to rise to USD 484 million by 2023 with a CAGR of 7.8%. The market is segmented by product type (Natural Superdisintegrants, Synthetic Superdisintegrants (modified starch, crospovidone, modified cellulose, ion exchange resins and calcium silicates) Application (Capsules and Tablets), and Therapeutic Area (gastrointestinal diseases, neurological diseases, oncology, infectious diseases, cardiovascular diseases, haematological diseases, and inflammatory diseases). Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.
The main factors driving the market are development of new superdisintegrants in pharmaceutical industry, growing population of geriatric and paediatric patients and growing generic drugs market. However, the markets growth is restricted by the declining financial investments for R&D fields. Although synthetic superdisintegrants have been the standard for many decades now, greater research into natural superdisintegrants will provide a motivation for the future growth of the market.
The synthetic superdisintegrant market segment held the largest share of the global superdisintegrants market. This is mainly accounted to the prevalent use of excipients such as sodium starch glycolate, and crospovidone in orally and fast disintegrating tablets. Rising incidences of cardiovascular diseases, neurological diseases, and other related diseases are further expected to drive the demand of fast disintegrating tablets, in-turn driving demand of superdisintegrants during the forecast period.
North America is leading the market while Europe is at second place. Increasing financial support for development of innovative oral dosage forms and constant effort devoted towards providing superior quality and compliant products in the market are the primary factors responsible for the dominance of North America and Europe in the market. Asia Pacific is expected to grow the fastest due to increasing healthcare spending, rising healthcare infrastructure and awareness and increasing outsourcing of excipient manufacturing to Asian countries like India and China.
Some of the key players dominating this market include Ashland, BASF SE, FMC Corporation, JRS Pharma, DFE Pharma, Roquette, The Dow Chemical Company, Asahi Kasei Corporation, Nippon Soda Co., and Huber Corporation.
Browse through the full report at https://www.marketdataforecast.com/market-reports/superdisintegrants-market-2862/ and checkout our recent reports in the Pharmaceuticals https://www.marketdataforecast.com/subcategory/pharmaceuticals-1/ For more insights and up-to-date industry news don’t forget subscribing to our newsletters.